Find and Pitch Jounalists, Get Your Story Covered

Tags: corticosteroids Acute asthma vomiting hay fever

	Profile	Recent Articles on Subject
1	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Final Thoughts - 1 day ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Arcellx to present positive data on multiple myeloma treatments - 18 days ago Scotland first in UK to approve new myeloma treatment - 2 months ago
3	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit - 19 days ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - about 1 month ago Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 8 months ago AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy - 12 months ago Prenatal Folate May Program Hematopoietic Stem Cell Function Into Adulthood - 12 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 2 months ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 3 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 8 months ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 8 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 10 months ago Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCT - 11 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 12 months ago Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL - about 1 year ago RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer - about 1 year ago
6	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 3 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 4 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 5 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 8 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 5 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 5 months ago Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients - 11 months ago
9	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study - 5 months ago FDA Approves Earlier Use of CAR-T Products for Myeloma - 8 months ago FDA Approves New Frontline Regimen for Aggressive ALL - 8 months ago FDA Approves First CAR-T for Chronic Lymphocytic Leukemia - 8 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - 11 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - 12 months ago MRD Tied to Allo-Transplant Benefit in NPM1-Mutated Acute Myeloid Leukemia - 12 months ago Benefits of Myeloma Regimens in the Real World Fall Well Short of Trials - 12 months ago Completely Oral Regimen Effective, Feasible in APL - 12 months ago
10	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - 8 months ago

Journalists covering acute promyelocytic leukemia